SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055043
Filing Date
2021-11-08
Accepted
2021-11-08 06:31:12
Documents
71
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyme-10q_20210930.htm   iXBRL 10-Q 2034239
2 EX-31.1 tyme-ex311_7.htm EX-31.1 12528
3 EX-31.2 tyme-ex312_8.htm EX-31.2 12472
4 EX-32.1 tyme-ex321_6.htm EX-32.1 8321
5 EX-99.1 tyme-ex991_71.htm EX-99.1 4286
  Complete submission text file 0001564590-21-055043.txt   8488870

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tyme-20210930.xsd EX-101.SCH 59917
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tyme-20210930_cal.xml EX-101.CAL 47220
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tyme-20210930_def.xml EX-101.DEF 205870
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyme-20210930_lab.xml EX-101.LAB 415164
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyme-20210930_pre.xml EX-101.PRE 342273
11 EXTRACTED XBRL INSTANCE DOCUMENT tyme-10q_20210930_htm.xml XML 1789371
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

IRS No.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38169 | Film No.: 211386437
SIC: 2834 Pharmaceutical Preparations